Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion.

Area of Science:

• Immunology
• Gastroenterology
• Pathophysiology

Background:

• Innate immune responses, specifically Toll-like receptor 4 (TLR4) and complement activation, are crucial in mesenteric ischemia/reperfusion (IR)-induced tissue damage.
• Understanding the regulatory mechanisms between TLR4 and complement is vital for mitigating intestinal IR injury.

Purpose of the Study:

• To investigate the intricate regulation of TLR4 and complement activation during intestinal IR in a murine model.
• To elucidate the roles of TLR4 and complement in mediating tissue damage, inflammation, and cytokine production following IR.

Main Methods:

• Utilized a mouse model of intestinal IR.
• Assessed C3 deposition, C3 and Factor B (FB) mRNA expression, and tissue damage.
• Administered the complement inhibitor CR2-Crry to wild-type and TLR4-deficient mice.
• Measured levels of IL-6 and IL-12p40.

Main Results:

• Intestinal IR induced C3 deposition in a TLR4-dependent manner.
• TLR4-deficient mice exhibited reduced damage and inflammation post-IR compared to wild-type mice.
• CR2-Crry treatment reduced complement activation and C3/FB transcription in wild-type mice but did not further decrease damage in TLR4-deficient mice.
• CR2-Crry significantly decreased IL-6 and IL-12p40 production in both genotypes.

Conclusions:

• TLR4 signaling regulates extrahepatic complement production during intestinal IR.
• Complement activation, in turn, modulates TLR4-mediated cytokine production in the context of intestinal IR.
• Targeting complement activation may offer therapeutic benefits by influencing TLR4-driven inflammatory pathways in IR.